United States · FDA National Drug Code directory

Pancreapar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44911-0681_373c3034-7f21-4ca8-b09e-469e3e85f899
Product NDC
44911-0681
Form
LIQUID
Composition / generic term
Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20230824
Source listing expiry
20261231

Source-listed ingredients

  • SYZYGIUM CUMINI SEED — 3 [hp_X]/mL
  • SUS SCROFA ADRENAL GLAND — 6 [hp_X]/mL
  • GOLDENSEAL — 6 [hp_X]/mL
  • SUS SCROFA PITUITARY GLAND — 6 [hp_X]/mL
  • SUS SCROFA PANCREAS — 6 [hp_X]/mL
  • KIDNEY BEAN — 9 [hp_X]/mL
  • ACETIC ACID — 12 [hp_X]/mL
  • LACTIC ACID, DL- — 12 [hp_X]/mL
  • PHOSPHORIC ACID — 12 [hp_X]/mL
  • PHOSPHORUS — 12 [hp_X]/mL
  • URANYL NITRATE HEXAHYDRATE — 15 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (44911-0681-1) · 44911-0681-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →